NVAX financials

Novavax (NVAX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

NVAX income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$1.12B$1.05B$452.80M$440.30M2.58
2024$682.16M$479.42M-$248.93M-$187.50M-1.23
2023$983.71M$639.94M-$566.51M-$545.06M-5.41
2022$1.98B$1.08B-$644.74M-$657.94M-8.42
2021$1.15B$1.15B-$1.69B-$1.74B-23.44
2020$475.60M$475.60M-$416.72M-$418.26M-7.27